Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

SP-26 dissolvable ketamine-based injectable implant targets chronic pain and fibromyalgia

Sever Pharma to scale-up extrusion processes and continue analytical testing for novel non-opioid treatment